CD40HVac, a therapeutic vaccine candidate for malignancies targeting dendritic cellsPARIS (BUSINESS WIRE) LinKinVax, a clinical-stage biotechnology company focusing on innovative protein-based vaccines, and Gustave Roussy, the leading cancer centre in Europe ranked third Best Cancer Hospital in the world, announce.